Stay updated on Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Publications section now includes a new Blood article citation with additional authors, and the previous Blood citation has been removed. This updates the study's referenced literature and author attribution.
    Difference
    0.1%
    Check dated 2026-07-11T05:46:35.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a new build of the page without altering visible content.
    Difference
    0.1%
    Check dated 2026-07-04T03:52:08.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2. This represents a minor internal update to the ClinicalTrials.gov study page and does not indicate changes to the study content visible to users.
    Difference
    0.1%
    Check dated 2026-06-26T23:53:53.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The study page now shows recruitment is closed ('No longer looking for participants'). It also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, along with a revision update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:00:30.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.4 to v3.5.5. This reflects a minor update to the page's versioning and metadata and does not modify any study data, eligibility criteria, outcomes, or locations.
    Difference
    0.1%
    Check dated 2026-06-05T10:27:54.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a small update to the page's revision metadata. No user-visible content changes are reflected by this update.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:28.000Z thumbnail image

Stay in the know with updates to Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.